Attached files
| file | filename |
|---|---|
| 8-K - 8-K - Cyclacel Pharmaceuticals, Inc. | a13-15500_18k.htm |
Exhibit 99.1
June 24, 2013
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K dated June 24, 2013, of Cyclacel Pharmaceuticals, Inc. and are in agreement with the statements contained in the third and fourth paragraphs therein. We have no basis to agree or disagree with other statements of the registrant contained therein.
/S/ Ernst & Young LLP
Metro Park, New Jersey